A detailed history of Altus Wealth Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Altus Wealth Group LLC holds 3,616 shares of ABBV stock, worth $615,985. This represents 0.31% of its overall portfolio holdings.

Number of Shares
3,616
Previous 3,430 5.42%
Holding current value
$615,985
Previous $588,000 21.43%
% of portfolio
0.31%
Previous 0.3%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $30,474 - $37,075
186 Added 5.42%
3,616 $714,000
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $12,146 - $13,839
76 Added 2.27%
3,430 $624,000
Q4 2023

Jan 29, 2024

SELL
$137.6 - $154.97 $31,097 - $35,023
-226 Reduced 6.31%
3,354 $519,000
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $3,339 - $3,866
-25 Reduced 0.69%
3,580 $533,000
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $41,078 - $51,119
310 Added 9.41%
3,605 $485,000
Q4 2022

Jan 18, 2023

BUY
$138.31 - $165.87 $70,399 - $84,427
509 Added 18.27%
3,295 $0
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $1,513 - $1,924
-11 Reduced 0.39%
2,786 $301,000
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $3,299 - $4,093
-25 Reduced 0.89%
2,797 $453,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $3,867 - $4,893
36 Added 1.29%
2,822 $382,000
Q3 2021

Nov 08, 2021

BUY
$106.4 - $120.78 $40,644 - $46,137
382 Added 15.89%
2,786 $301,000
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $67,518 - $74,329
-660 Reduced 21.54%
2,404 $274,000
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $246,621 - $332,964
3,064 New
3,064 $329,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Altus Wealth Group LLC Portfolio

Follow Altus Wealth Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altus Wealth Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altus Wealth Group LLC with notifications on news.